Related Experiment Video

Updated: Apr 18, 2026

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

10.9K

DNA helicases FANCM and DDX11 are determinants of PARP inhibitor sensitivity

Chantal Stoepker1, Atiq Faramarz1, Martin A Rooimans1

  • 1Department of Clinical Genetics, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands.

DNA Repair
|January 14, 2015
PubMed

Insights

Researchers explored the Fanconi anemia (FA) pathway for new predictors of PARP inhibitor sensitivity in BRCA-mutated cancers. They found FANCM and DDX11 DNA helicases influence response, potentially expanding PARP inhibitor use.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • PARP inhibitors show promise for BRCA1/2-mutated cancers.
  • The Fanconi anemia (FA) pathway is crucial for DNA repair, including homologous recombination.
  • Identifying additional determinants of PARP inhibitor sensitivity is important.

Purpose of the Study:

  • To investigate the Fanconi anemia (FA) pathway for novel predictors of PARP inhibitor sensitivity.
  • To analyze the role of specific FA pathway components in response to PARP inhibitors.

Main Methods:

  • Testing PARP inhibitor sensitivity in lymphoblastoid cell lines from individuals with Fanconi anemia (FA) and related syndromes.
  • Analyzing the correlation between specific FA pathway mutations and drug response.

Main Results:

  • Significant variability in PARP inhibitor sensitivity was observed among FANCD1/BRCA2-deficient lymphoblasts.
  • The DNA helicases FANCM and DDX11 were identified as key determinants of PARP inhibitor response.
  • PARP inhibitor sensitivity is dependent on the specific type of FANCD1/BRCA2 mutation.

Conclusions:

  • The Fanconi anemia (FA) pathway contains additional determinants of PARP inhibitor sensitivity beyond BRCA1/2.
  • FANCM and DDX11 are novel predictors of response to PARP inhibitors.
  • These findings may broaden the application of PARP inhibitors in cancer therapy.
Keywords:
DDX11FANCMFanconi anemiaPARP inhibitorSister chromatid cohesionWarsaw breakage syndrome

More Related Videos

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

4.7K
Detection of Post-Replicative Gaps Accumulation and Repair in Human Cells Using the DNA Fiber Assay10:32

Detection of Post-Replicative Gaps Accumulation and Repair in Human Cells Using the DNA Fiber Assay

Published on: February 3, 2022

8.5K

Related Concept Videos

DNA Helicases00:55

DNA Helicases

DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
25.3K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.6K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
8.4K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
66.0K